Revitalist Lifestyle and Wellness Ltd. RVLWF

Company Overview

Revitalist Lifestyle and Wellness Ltd. is a Canada-based wellness and mental health services company focused on psychedelic-assisted therapy, ketamine treatment programs, and integrated behavioral health services. The company operates primarily in the mental health and wellness sector, with an emphasis on treating conditions such as depression, anxiety, post-traumatic stress disorder (PTSD), chronic pain, and substance use disorders through physician-supervised treatment protocols. Public filings and company disclosures identify ketamine-assisted therapy and related clinical wellness services as core revenue drivers.

The company developed through a combination of clinic expansion, acquisitions, and branding initiatives centered on alternative mental health care delivery. Revitalist has operated clinics in the United States while maintaining corporate ties to Canada through its public listing structure. Its positioning has been tied to growing demand for nontraditional mental health treatments and the broader emerging psychedelic medicine market. Public disclosures indicate that the company has sought to differentiate itself through integrated care models combining medical oversight, wellness services, and patient support programs. Certain historical operational details vary across public disclosures and market summaries; where inconsistencies exist, data is inconclusive based on available public sources.

Business Operations

Revitalist generates revenue primarily through patient treatment services delivered via its clinic network and affiliated wellness operations. Its core business activities have included ketamine infusion therapy, psychiatric evaluations, counseling services, wellness coaching, and related behavioral health offerings. The company has historically referenced operating through clinic-based treatment centers in the United States, with reported exposure to states including Tennessee and other regional markets. Revenue has largely been tied to direct patient care and treatment program fees.

The company has also referenced operational interests in broader psychedelic medicine infrastructure and wellness-oriented healthcare expansion. Public disclosures have identified clinic assets, treatment protocols, and healthcare practitioner networks as important operational components. Revitalist has pursued relationships with healthcare providers and affiliated treatment professionals to support service delivery. Information regarding current joint ventures, active subsidiaries, or material strategic partnerships is limited in recent publicly available filings, and some operational details appear to have changed over time. Data is inconclusive based on available public sources regarding the current status of certain clinic operations and expansion plans.

Strategic Position & Investments

Revitalist’s strategic direction has centered on expanding access to alternative mental health therapies and positioning itself within the emerging psychedelic-assisted treatment sector. The company has publicly discussed growth initiatives involving clinic expansion, patient access programs, practitioner recruitment, and broader behavioral wellness integration. Strategic messaging in investor materials has emphasized increasing public acceptance of ketamine-assisted treatment and the potential future commercialization of psychedelic therapies as regulatory frameworks evolve.

The company has previously pursued acquisitions and operational expansion initiatives designed to increase its clinic footprint and treatment capacity. Public records reference investment activity connected to treatment centers and healthcare infrastructure supporting mental health services. Revitalist has also communicated interest in emerging sectors tied to psychedelic medicine, integrative wellness, and mental healthcare innovation. However, the timing, scale, and current operational status of some previously announced initiatives are not consistently verified across recent filings and market reporting. Data is inconclusive based on available public sources regarding the present status of certain investment initiatives and strategic expansion targets.

Geographic Footprint

Revitalist Lifestyle and Wellness Ltd. is headquartered in Canada through its corporate structure while historically operating treatment clinics primarily in the United States. Public disclosures and investor materials indicate operational concentration in select U.S. regional markets where ketamine-assisted therapy regulations permit clinical treatment delivery. The company’s market presence has been tied mainly to North American mental health and wellness services.

The company has referenced ambitions for broader geographic expansion within the United States and participation in the wider international psychedelic wellness industry. Its operational influence appears concentrated in North America, with limited verified evidence of material operating assets outside the region. While the company has maintained visibility in publicly traded Canadian capital markets, available public information does not confirm significant international clinic operations beyond the United States. Data is inconclusive based on available public sources regarding current active clinic counts and international operating reach.

Leadership & Governance

Revitalist has been led by executives with backgrounds in healthcare operations, wellness services, and business development tied to behavioral health markets. Corporate governance and leadership communications have emphasized expanding patient access to mental health treatment alternatives, developing scalable clinic operations, and participating in the evolving psychedelic medicine sector. Public company disclosures indicate leadership focus on regulatory compliance, treatment accessibility, and long-term positioning within alternative mental healthcare markets.

Key executives identified in public filings and company disclosures include:

• Kathryn Walker – Chief Executive Officer
• David Krell – Former Chief Executive Officer and Chairman
• Brian T. Ferguson – Former Chief Financial Officer

Leadership composition and executive roles have changed periodically during the company’s development. Some executive appointments and governance updates differ across historical disclosures and market databases; therefore, certain leadership information is inconclusive based on available public sources.